Activist 13D/13G Filings - Qualigen Therapeutics Inc. (QLGN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-05-27
09:22 am
Purchase
13GQUALIGEN THERAPEUTICS INC
QLGN
ALPHA CAPITAL ANSTALT3,525,042
9.99%
2,284,954increase
(+184.26%)
View
2022-01-04
9:08 pm
Sale
13GQUALIGEN THERAPEUTICS INC
QLGN
SABBY MANAGEMENT LLC0
0%
-1,960,000decrease
(Position Closed)
View
2021-12-06
5:04 pm
Purchase
13GQUALIGEN THERAPEUTICS INC
QLGN
SABBY MANAGEMENT LLC1,960,000
11%
1,960,000increase
(New Position)
View
2020-06-01
5:00 pm
Purchase
13GQUALIGEN THERAPEUTICS INC
QLGN
SEKISUI DIAGNOSTICS LLC1,980,233
15.8%
1,980,233increase
(New Position)
View
2020-06-01
4:46 pm
Purchase
13GQUALIGEN THERAPEUTICS INC
QLGN
Greenblock Capital LLC811,431
6.5%
811,431increase
(New Position)
View
2020-05-28
4:05 pm
Purchase
13GQUALIGEN THERAPEUTICS INC
QLGN
ALPHA CAPITAL ANSTALT1,240,088
9.9%
1,240,088increase
(New Position)
View
2020-02-14
09:56 am
Sale
13GRITTER PHARMACEUTICALS INC
RTTR
Alyeska Investment Group L.P.425,000
4.2%
-147,890decrease
(-25.81%)
View
2020-01-28
7:18 pm
Sale
13GRITTER PHARMACEUTICALS INC
RTTR
Step Michael D128,757
0.7%
-820,077decrease
(-86.43%)
View
2020-01-28
4:15 pm
Sale
13GRITTER PHARMACEUTICALS INC
RTTR
Stonehenge Partners LLC334,872
1.7%
-812,317decrease
(-70.81%)
View